<i>EXTL3</i> mutations cause skeletal dysplasia, immune deficiency, and developmental delay
2017 · The Journal of Experimental Medicine · 83 citations
https://doi.org/10.1084/jem.20161525
I
Ileana Bortolomai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
1.4K
Citations
22
h-index
24
i10-index
Ileana Bortolomai is an academic researcher. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Immune Cell Function and Interaction & Cancer Research and Treatments. The author has an h-index of 22, co-authored 33 publications.
ORCID: 0000-0002-2592-1274Papers by this author
worksDownregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy
2012 · British Journal of Cancer · 58 citations
https://doi.org/10.1038/bjc.2012.132
HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor
2013 · Gynecologic Oncology · 46 citations
https://doi.org/10.1016/j.ygyno.2013.08.033
Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth
2018 · Journal of Experimental & Clinical Cancer Research · 29 citations
https://doi.org/10.1186/s13046-018-0796-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat